Fig. 3
From: Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

Gating strategy in normal BM to identify CD34+/CD38−/CD123+ cells
From: Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
Gating strategy in normal BM to identify CD34+/CD38−/CD123+ cells